Back to search
Cannabis Use Disorder, Moderate
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Cannabis Use Disorder, Moderate trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Cannabis Use Disorder, Moderate trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This research study evaluates the effects of an FDA-approved medication Gabapentin in individuals with Bipolar Disorder who smoke marijuana. Participants in the…
Cannabis is the most commonly used psychoactive substance in Canada (Lowry \& Corsi, 2020). A sub-group of cannabis users develop a condition known as Cannabis…
Cannabis is the most commonly used psychoactive substance in Canada (Lowry \& Corsi, 2020). A sub-group of cannabis users develop Cannabis Use Disorder (CUD). C…
The purpose of this study is to test a text-delivered counseling program to stop or reduce cannabis use among young adults (ages 18 to 25).